Get started
Author

Brett Lauring

Observed institution: Kallyope (United States)
ORCID: 0009-0007-6267-0017
Observed ORCID: 0009-0007-6267-0017
OpenAlex ID: A5093969360
Gut enteroendocrine cell activation using a combination of GPR119 and GPR40 agonists results in synergistic hormone secretion in mice and humans
2025 · Iyassu K. Sebhat, Monika J.M. Murphy, et al. · Cell Metabolism · 8
Combined GPR40 and GPR119 full agonism with K‐757 and K‐833 results in robust glucose lowering and modest weight loss in overweight/obese subjects with T2DM
2025 · Michael Crutchlow, Jiajun Liu, et al. · Diabetes Obesity and Metabolism · 4
Combined agonism of nutrient receptors GPR40 and GPR119 with K‐757 and K‐833 results in weight loss and blood pressure reductions in obese subjects without type 2 diabetes mellitus
2025 · Michael Crutchlow, Jiajun Liu, et al. · Diabetes Obesity and Metabolism · 3
Discovery of Gut-Targeted GPR40 Agonist K-757 and GPR119 Agonist K-833, a Combination Treatment for Metabolic Disorders
2025 · Christopher R. Moyes, Shuwen He, et al. · Journal of Medicinal Chemistry · 3
TRPM 8 Antagonism with Elismetrep: A Novel Approach for Treating Migraine (S37.001)
2026 · Brett Lauring, Peter Goadsby, et al. · Neurology
Author response for "Combined agonism of nutrient receptors GPR40 and GPR119 with K‐757 and K‐833 results in weight loss and blood pressure reductions in obese subjects without type 2 diabetes mellitus "
2025 · Michael Crutchlow, Jiajun Liu, et al. · Publons reviews and discussion
K757 and K833 multiple-dose study in healthy subjects
2024 · Rajkumar Chetty, Annemarie Vance, et al. · http://isrctn.com/
Works count: 7
Citation count: 18
H-index: 3
I10-index:
Year
Topic
Type